Acetyl Hexapeptide-3 (Argireline) dosing & administration
SNARE complex inhibitor that reduces expression wrinkles through topical neuromuscular modulation — the 'Botox in a bottle' peptide.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Dosing
How much do I take?
Topical: Applied onto the skin as a cream, gel, or lotion — it works mainly where you put it.
Bioavailability Local — acts mainly at the skin; little reaches the bloodstream.
5-10% concentration (cream or serum)
Frequency
Twice daily (morning and evening)
Duration
Minimum 28-30 days; ongoing use to maintain effect
Timing
Best time to take
Apply Acetyl Hexapeptide-3 (Argireline) to clean, dry skin. For best results, use consistently at the same time(s) each day. Evening application is often preferred to allow overnight absorption, unless otherwise directed.
With food?
As a topical product, Acetyl Hexapeptide-3 (Argireline) is not affected by food intake. Apply to clean skin and allow adequate absorption time before covering the area.
If stacking
Acetyl Hexapeptide-3 (Argireline) should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting your dose
Increase if
- You've tolerated the current dose for the recommended period without significant side effects
- Therapeutic goals haven't been met at the current dose level
- Your healthcare provider recommends dose escalation based on your response
- Lab work or clinical assessments support a higher dose
Decrease if
- Side effects are bothersome or impacting daily life despite management strategies
- You experience any signs of an adverse reaction
- Lab results indicate the need for dose reduction
- Your healthcare provider recommends a lower dose based on your response
Signs of right dose
- Therapeutic goals being met with minimal side effects
- Stable and consistent response to treatment
- Lab values or clinical markers trending in the right direction
- Good tolerance with manageable or absent side effects
Administration
How do I use it?
Reconstitution
What you need
Injection
Route
Acetyl Hexapeptide-3 (Argireline) is administered Topical—no injection required
Best sites
Storage
Before reconstitution
Store Acetyl Hexapeptide-3 (Argireline) in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
After reconstitution
Once reconstituted, Acetyl Hexapeptide-3 (Argireline) should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation — discard the vial
Sample daily schedule
As prescribed (once daily)
As prescribed by your healthcare provider injection
Site: Topical—rotate sites if applicable
Maintain a consistent schedule for optimal results with Acetyl Hexapeptide-3 (Argireline). Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.
Safety
Is it safe?
Side effects
Commonly reported: Mild Skin Irritation, Transient Redness, Slight Dryness, Stinging on Compromised Skin
Less common: Contact Dermatitis
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Acetyl Hexapeptide-3 (Argireline)
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Acetyl Hexapeptide-3 (Argireline) should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Flagged pairings
- Vitamin C at Very Low pH (<3.5) — Use with caution—discuss with your healthcare provider.
- Benzoyl Peroxide — Use with caution—discuss with your healthcare provider.
- Strong AHA/BHA Peels — Use with caution—discuss with your healthcare provider.
Published research
What the studies show
Wang Y, et al. · 2013
A landmark clinical trial showed 48.9% wrinkle reduction in Chinese subjects using 10% Argireline over 4 weeks—significantly better than placebo. Skin roughness decreased across all measured parameters, proving this peptide's effectiveness at reducing expression lines.
Wang Y, et al. · 2013
This multicenter study confirmed Argireline achieved 48.9% wrinkle reduction in humans while increasing type I collagen in aged mice—about 40% more collagen was produced. Both human skin and animal models showed dramatic improvements in skin structure.
Wang Y, et al. · 2013
Aged mice treated with Argireline showed improved skin histology with type I collagen increased significantly while type III collagen decreased. The peptide successfully reversed aging-related skin deterioration at the cellular level.
Blanes-Mira C, et al. · 2002
In vitro mechanistic studies confirmed that Argireline inhibits neurotransmitter release by preventing SNARE complex formation—the same biological target as botulinum toxin. This competitive mechanism works without the risks of injectable neurotoxins.
Grosicki M, et al. · 2014
Safety testing demonstrated Argireline is non-cytotoxic to human cell lines with a 100-fold safety margin over toxic reference compounds. No genotoxicity was detected, establishing exceptional safety for cosmetic use.
Head to head
Acetyl Hexapeptide-3 (Argireline) compared
Want the full picture?
The complete Acetyl Hexapeptide-3 (Argireline) research profile: mechanism of action, clinical studies, effectiveness timeline, and FAQ.